These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 29017454)
21. Indirect costs associated with metastatic breast cancer. Wan Y; Gao X; Mehta S; Wang Z; Faria C; Schwartzberg L J Med Econ; 2013 Oct; 16(10):1169-78. PubMed ID: 23866016 [TBL] [Abstract][Full Text] [Related]
22. [Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group]. Wrona W; Hermanowski T; Jakubczyk M; Golicki D; Czech M; Niewada M; Kolasa K Przegl Epidemiol; 2011; 65(1):153-7. PubMed ID: 21735853 [TBL] [Abstract][Full Text] [Related]
23. Social costs of loss in productivity-related absenteeism in Poland. Genowska A; Fryc J; Pinkas J; Jamiołkowski J; Szafraniec K; Szpak A; Bojar I Int J Occup Med Environ Health; 2017 Oct; 30(6):917-932. PubMed ID: 28584315 [TBL] [Abstract][Full Text] [Related]
24. Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs. Bencina G; Chami N; Hughes R; Weston G; Baxter C; Maciejczyk A; Popovic L; Karamousouli E; Salomonsson S J Med Econ; 2023; 26(1):254-261. PubMed ID: 36756852 [TBL] [Abstract][Full Text] [Related]
25. Economic burden from smoking-related diseases in Thailand. Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527 [TBL] [Abstract][Full Text] [Related]
26. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs. Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457 [TBL] [Abstract][Full Text] [Related]
27. Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore. Cher BP; Chen C; Yoong J BMJ Open; 2017 Apr; 7(4):e014377. PubMed ID: 28389491 [TBL] [Abstract][Full Text] [Related]
28. Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity. Ganapathy V; Graham GD; DiBonaventura MD; Gillard PJ; Goren A; Zorowitz RD Clin Interv Aging; 2015; 10():1793-802. PubMed ID: 26609225 [TBL] [Abstract][Full Text] [Related]
30. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland. Kawalec P; Malinowski KP; Pilc A Rheumatol Int; 2016 Sep; 36(9):1223-30. PubMed ID: 27339273 [TBL] [Abstract][Full Text] [Related]
31. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study. Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559 [TBL] [Abstract][Full Text] [Related]
32. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland. Kawalec PP; Malinowski KP Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642 [TBL] [Abstract][Full Text] [Related]
33. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature]. Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852 [TBL] [Abstract][Full Text] [Related]
34. Economic burden of depression in South Korea. Chang SM; Hong JP; Cho MJ Soc Psychiatry Psychiatr Epidemiol; 2012 May; 47(5):683-9. PubMed ID: 21526429 [TBL] [Abstract][Full Text] [Related]
35. Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer. Parsekar K; Howard Wilsher S; Sweeting A; Patel A; Fordham R; ; ; ; ; BMJ Open; 2021 Jan; 11(1):e039412. PubMed ID: 33431487 [TBL] [Abstract][Full Text] [Related]
36. Economic Burden of Mental Illnesses in Pakistan. Malik MA; Khan MM J Ment Health Policy Econ; 2016 Sep; 19(3):155-66. PubMed ID: 27572143 [TBL] [Abstract][Full Text] [Related]
37. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Hanly P; Timmons A; Walsh PM; Sharp L Value Health; 2012 May; 15(3):429-36. PubMed ID: 22583452 [TBL] [Abstract][Full Text] [Related]
38. Production lost due to cervical cancer in Poland in 2012. Dubas-Jakóbczyk K; Kocot E; Seweryn M; Koperny M Med Pr; 2016; 67(3):289-99. PubMed ID: 27364103 [TBL] [Abstract][Full Text] [Related]
39. Economic burden of breast cancer in northern Serbia. Milovic M; Tamas T; Crnobrnja V; Paut Kusturica M Front Public Health; 2023; 11():1265301. PubMed ID: 38162600 [TBL] [Abstract][Full Text] [Related]
40. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method]. Wegner C; Gutsch A; Hessel F; Wasem J Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]